Can a nightly eye drop stop kids' eyesight from getting worse?
NCT ID NCT07456488
First seen Mar 07, 2026 · Last updated Jun 23, 2026 · Updated 18 times
Summary
This study tests whether a very low dose of atropine eye drops (0.01%) given once nightly can slow the progression of nearsightedness (myopia) in children aged 4 to 16. Over 6 months, 60 children will either receive the drops or be in a control group. The goal is to see if the drops reduce the lengthening of the eye and slow the need for stronger glasses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LiaquatNHMC
RECRUITINGKarachi, Sindh, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atropine 0.01% eye drops
What this could lead to
If it works, this could offer a simple way to slow down worsening nearsightedness in children, reducing the need for stronger glasses later.
What could go wrong
This is a small, early-phase study with only 60 children. The effect may be modest, and long-term safety or benefits are not yet known.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.